As per the article, calling this a "success" is a little over the top. Out of 16 patients, it stopped progression of tumour in 5 had stopped but it doesn't say

As per the article, calling this a "success" is a little over the top. Out of 16 patients, it stopped progression of tumour in 5 had stopped but it doesn't say it decreased. Moreover for 2, it had adverse reactions when admittedly the dosage was low. I won't call that a success. IT is a good start and promising result. "Success" would mean at least 50% patients REDUCED the tumour. So let us not hold our breath yet